Strs Ohio decreased its holdings in shares of Encompass Health Corp (AMEX:EHC) by 75.6% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 9,457 shares of the company’s stock after selling 29,243 shares during the period. Strs Ohio’s holdings in Encompass Health were worth $640,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd acquired a new position in Encompass Health during the 2nd quarter worth approximately $107,000. Meeder Asset Management Inc. increased its position in Encompass Health by 97.0% during the 2nd quarter. Meeder Asset Management Inc. now owns 2,092 shares of the company’s stock worth $142,000 after purchasing an additional 1,030 shares during the period. First Mercantile Trust Co. acquired a new position in Encompass Health during the 1st quarter worth approximately $142,000. Point72 Asia Hong Kong Ltd acquired a new position in Encompass Health during the 1st quarter worth approximately $142,000. Finally, Mount Yale Investment Advisors LLC acquired a new position in Encompass Health during the 1st quarter worth approximately $143,000. Institutional investors own 93.18% of the company’s stock.
Several research firms have issued reports on EHC. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 target price on the stock in a research report on Friday, July 27th. Piper Jaffray Companies upgraded Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Credit Suisse Group boosted their target price on Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, July 26th. Mizuho reiterated a “buy” rating and set a $82.00 target price on shares of Encompass Health in a research report on Thursday, July 26th. Finally, SunTrust Banks reiterated a “buy” rating and set a $82.00 target price on shares of Encompass Health in a research report on Friday, July 20th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $71.10.
EHC opened at $57.67 on Wednesday. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. Encompass Health Corp has a 1-year low of $40.86 and a 1-year high of $59.29.
Encompass Health (AMEX:EHC) last released its quarterly earnings results on Wednesday, July 25th. The company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.16. The business had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The company’s quarterly revenue was up 10.5% on a year-over-year basis. equities research analysts predict that Encompass Health Corp will post 2.72 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be issued a $0.27 dividend. The ex-dividend date is Friday, September 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.87%. This is a boost from Encompass Health’s previous quarterly dividend of $0.25.
In related news, insider Cheryl B. Levy sold 28,955 shares of the company’s stock in a transaction that occurred on Friday, August 3rd. The stock was sold at an average price of $78.00, for a total value of $2,258,490.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Andrew L. Price sold 9,457 shares of the company’s stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $80.04, for a total value of $756,938.28. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Featured Story: Book Value Per Share in Stock Trading
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.